Company Search:
Advanced Search
Sponsored Links
IXICO PLC Company Snapshot
IXICO PLC operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other companies in this sector in the United Kingdom: Oxford Biodynamics PLC (2016 sales of £1.09 million [US$1.36 million] of which 100% was Pharmaceutical), Genedrive PLC (£5.06 million [US$6.31 million] of which 40% was Preclinical Research services), and Avacta Group Plc (£2.17 million [US$2.70 million] of which 67% was Animal Health).

Sales Analysis. IXICO PLC reported sales of £3.11 million (US$3.88 million) for the fiscal year ending September of 2016. This represents a decrease of 0.1% versus 2015, when the company's sales were £3.12 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for IXICO PLC
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 26.50p
(Figures in Pounds Sterling)
1 Week -7.0%   13 Weeks -22.1%  
4 Weeks -15.9%   52 Weeks -32.9%  
  Ticker: IXI Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 3,111,000
(Year Ending Jan 2017).
Employees: 69
  Currency: Pounds Sterling Market Cap: 7,171,770
  Fiscal Yr Ends: September Shares Outstanding: 27,063,284
  Share Type: Ordinary Closely Held Shares: 14,809,858
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.